The Leadership Team at Skye Bioscience oversees the strategic direction and operational execution of the company’s mission to develop innovative cannabinoid-based therapies. Comprising key executives such as the CEO and Chief Financial Officer, this team collaborates to secure funding, drive research and development initiatives, and engage with regulatory bodies, ensuring the company meets its goals in addressing significant medical needs.
View all